Ulthera to Present at Two Upcoming Healthcare Conferences
24th Annual Piper Jaffray Healthcare Conference; Canaccord Genuity Medical Technology & Diagnostics Forum
(firmenpresse) - MESA, AZ -- (Marketwire) -- 11/26/12 -- Matthew Likens, president and CEO of , Inc. -- a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology -- is scheduled to present at two upcoming healthcare conferences:
24th Annual in New York City, Nov. 27-28, 2012
Location: The New York Palace Hotel, 455 Madison Avenue, New York, NY
6th Annual Forum in New York, Dec. 4, 2012
Location: Le Parker Meridien, 119 West 56th Street, New York, NY
Likens will present an overview of the company as well as its accomplishments to date and prospects for the future.
Ulthera, Inc. is a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is cleared to lift skin on the brow, neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top-tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit .
Lindsey Karberg
Ulthera, Inc.
480.336.1744
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.11.2012 - 08:40 Uhr
Sprache: Deutsch
News-ID 1174196
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MESA, AZ
Phone:
Kategorie:
Venture Capital
Anmerkungen:
Diese Pressemitteilung wurde bisher 128 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ulthera to Present at Two Upcoming Healthcare Conferences
"
steht unter der journalistisch-redaktionellen Verantwortung von
Ulthera (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
